After the sale, Mr. Orsinger will stay with the company with a reduced base salary of $700,000 and the opportunity for bonuses. Johnson & Johnson agreed to purchase Synthes for $21.3 billion in April.
Related Articles on Orthopedic Device Companies:
Medtronic Launches T2 Altitude Expandable Corpectomy Device
ArthroCare to Settle Private Securities Class Action Suit
Bacterin Signs Distribution Agreement With Jeil for LeForte System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.